Search Results - Almudena Barbero-Castillo
- Showing 1 - 1 results of 1
-
1
Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks by Elke L. M. ter Haar, Juul M. P. A. van den Reek, Kristian Gaarn Du Jardin, Almudena Barbero-Castillo, Elke M. G. J. de Jong, Satish F. K. Lubeek
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book